Table III.
Cox proportional hazard models on the overall survival rate of lung AC patients.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Factor | P-value | HR (95% CI) | P-value | HR (95% CI) |
Gender (male vs. female) | 0.983 | 1.005 (0.616–1.640) | 0.855 | 0.922 (0.386–2.202) |
Age, years (<63 vs. ≥63) | 0.055 | 0.618 (0.378–1.010) | 0.115 | 2.287 (0.817–6.402) |
MCT-4 expression (low vs. high) | 0.000 | 3.267 (1.851–5.767) | 0.001 | 3.192 (1.804–5.646) |
Invasion depth (T1/2 vs. T3/4) | 0.026 | 0.501 (0.272–0.921) | 0.314 | 1.433 (0.711–2.887) |
Lymph node metastasis (N0 vs. N1/2/3/X) | 0.018 | 0.554 (0.340–0.904) | 0.057 | 0.272 (0.071–1.041) |
Distant metastasis (M0 vs. M1) | 0.948 | 1.048 (1.048–4.288) | 0.633 | 0.821 (0.365–1.847) |
TNM stage (I/II vs. III/IV) | 0.005 | 2.150 (1.258–3.674) | 0.007 | 2.084 (1.217–3.569) |
Histological type (invasive AC vs. variant invasive AC) | 0.627 | 1.215 (0.554–2.663) | 0.431 | 0.502 (0.090–2.791) |
AC, adenocarcinoma; HR, hazard ratio; CI, confidence interval; MCT-4, monocarboxylate transporter 4.